Clinical trial Recruiting at 1 site Interventional Ages 6 and up

Virtual reality to distract from pain and anxiety during blood cancer procedures

Official title: Virtual Reality to Reduce Pain and Anxiety in Hematological Cancer Patients Undergoing Invasive Procedures: Protocol for a Crossover Clinical Trial

Run by University of Sfax · NCT07085065 · Data updated 2026-11-12

This project tries whether wearing a virtual reality headset during procedures can reduce pain and anxiety for people aged 6 and older with blood cancers.

More Anxiety trials

Quick facts

Study typeInterventional
Ages6 Years and up
SexAll
Enrollment365 (estimated)
SponsorUniversity of Sfax
Academic / other
Drugs / interventionsChemotherapy
Locations1 site (Tunis, Sfax Governorate)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedJuly 31, 2025
Study endsJuly 31, 2025
Registry record updatedJuly 25, 2025
Trial IDNCT07085065 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 6 or older with a confirmed hematologic malignancy who will undergo bone marrow biopsy/aspiration, lumbar puncture, venipuncture, or chemotherapy.

Probably not a fit

Patients with unstable or photosensitive epilepsy, significant hearing/visual/inner-ear impairments, severe psychiatric or cognitive disorders, active contagious diseases, communication difficulties, or those who remove the VR headset during the procedure may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective interventional crossover trial where each participant first receives standard care during a procedure, has at least a seven-day washout, and then repeats the procedure with a VR session so each patient can act as their own control; an external matched-control group by age and procedure type is also included. Procedures covered include bone marrow biopsy and aspiration, lumbar puncture, venipuncture, and some chemotherapy visits. The intervention is a VR session delivered during the procedure intended to distract patients and lower perceived pain and anxiety. Outcomes compare patient-reported pain and anxiety between the standard-care and VR sessions.

Why it matters

Potential benefit: If successful, VR could lower pain and anxiety during invasive procedures and make those visits more comfortable for patients with hematologic malignancies.

How similar studies have gone: Previous smaller studies in other clinical settings have shown that VR can reduce procedure-related pain and anxiety, but high-quality data specifically in hematologic malignancy procedures remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* being ≥ 6 years old
* having a confirmed diagnosis of a hematological malignancy
* undergoing at least one of the following procedures: Bone Marrow Biopsy, Bone Marrow Aspiration, Lumbar Puncture, Venipuncture, or Chemotherapy.

Exclusion Criteria:

* unstable or photosensitive epilepsy
* hearing, visual, or inner ear impairments
* severe psychiatric, cognitive, or mental disorders
* Contagious diseases
* Communication difficulties
* Patients who withdraw consent
* Patient who remove the VR headset during the procedure

Where it's running

  • Clinical hematology department of unversity hospital of Hedi Chaker of Sfax, Tunisia
    Tunis, Sfax Governorate, Tunisia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.